Ignite Creation Date:
2024-05-06 @ 6:22 PM
Last Modification Date:
2024-10-26 @ 2:47 PM
Study NCT ID:
NCT05646381
Status:
RECRUITING
Last Update Posted:
2024-06-24
First Post:
2022-12-02
Brief Title:
A Multicenter Trial Assessing the Impact of Lipoproteina Lowering With Pelacarsen TQJ230 on the Progression of Calcific Aortic Valve Stenosis
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Organization Data
Organization:
Novartis
Class:
INDUSTRY
Study ID:
CTQJ230A12203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Novartis Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None